Drug Safety

Perioperative Safety of Aprotinin in Coronary Artery Bypass Graft Surgery: Is there Life After BART?
pp. 557-560(4)
Author: Augoustides, John G.

Benefit-Risk Assessment of Telithromycin in the Treatment of Community-Acquired Pneumonia
pp. 561-575(15)
Author: Brown, Steven D.

Memantine for the Treatment of Alzheimer's Disease: Tolerability and Safety Data from Clinical Trials
pp. 577-585(9)
Authors: Farlow, Martin R.; Graham, Stephen M.; Alva, Gustavo

Risk Management of Simvastatin or Atorvastatin Interactions with CYP3A4 Inhibitors
pp. 587-596(10)
Authors: Molden, Espen; Skovlund, Eva; Braathen, Pia

Ethnic Differences in the Risks of Adverse Reactions to Drugs Used in the Treatment of Psychoses and Depression: A Systematic Review and Meta-Analysis
pp. 597-607(11)
Authors: Ormerod, Sara; McDowell, Sarah E.; Coleman, Jamie J.; Ferner, Robin E.

Influence of Regulatory Measures on the Rate of Spontaneous Adverse Drug Reaction Reporting in Italy
pp. 609-616(8)
Authors: Motola, Domenico; Vargiu, Antonio; Leone, Roberto; Conforti, Anita; Moretti, Ugo; Vaccheri, Alberto; Velo, Giampaolo; Montanaro, Nicola

Safety of Low-Dose Aprotinin in Coronary Artery Bypass Graft Surgery: A Single-Centre Investigation in 2436 Patients in Germany
pp. 617-626(10)
Authors: Kluth, Mario; Lueth, Jan U.; Zittermann, Armin; Lanzenstiel, Markus; Koerfer, Reiner; Inoue, Kazuo

Occurrence of Community-Acquired Respiratory Tract Infection in Patients Receiving Esomeprazole: Retrospective Analysis of Adverse Events in 31 Clinical Trials
pp. 627-636(10)
Authors: Estborn, Lennart; Joelson, Svante